The goal of Singapore-Stanford Biodesign (SSB) is to train the next generation of medical technology innovators in Asia.
This highly competitive program is directed towards Singaporean citizens who have an interest in the invention and early-stage development of new medical technologies. Successful applicants should have advanced degrees and/or significant work experience.
The SSB Fellowship Program is centered in the Biopolis in Singapore and is administered as a collaboration between Stanford University, the Singapore Economic Development Board (EDB), the Agency for Science, Technology and Research (A*STAR). A separate but linked SSB graduate class is also under planning with the National University of Singapore (NUS) and the Nanyang Technological University (NTU).
SSB Fellows will receive tuition, stipend, and international travel support. During the fellowship, six months of the fellows’ time is spent at Stanford, and six months in Singapore. Fellows work in a multidisciplinary team joining other innovators with a combination of engineering, medical and business back- grounds. The fellowship may be extended an additional six months if projects require further development.
The team examines clinical needs within the Singaporean and other Asian settings, identifying opportunities for medical technology innovation. Working closely with EDB, A*STAR advisors and Stanford, NUS and NTU faculty, the teams invent, prototype, develop and patent one or more new technologies. Fellows are also mentored by “real-world” experts from the medical technology, legal and venture capital industries in the United States and Singapore.
A new center will be developed at the Biopolis, the hub for biomedical innovaiton in Singapore.
Science and Engineering Institutes: Agency for Science, Technology and Research
61 Biopolis Drive #01-02 Proteos Buliding Singapore 138673
DID: +65 6419 6518
Fax: +65 6478 9703
N E W S
July 2013 THOUGHT LEADERS SERIES 2013: Innovations in Robotics Surgery
26 August 2013 | 2:00-5:00PM
The Singapore-Stanford Biodesign (SSB) Thought Leaders Series is SSB’s signature event, where we invite key opinion leaders to Singapore to share and discuss the latest industry insights and experiences on medical device innovation.
Dr. Frederic Moll
CEO, Auris Robotics Surgery;
Founder, Intuitive Surgical Inc.
Prof. Christopher Cheng
Senior Consultant, Urology, Singapore General Hospital;
Pro-term CEO, Sengkang General Hospital
A/Prof Louis Phee
Head, School of Mechanical & Aerospace Engineering, NTU, Co-founder, Endomaster Pte Ltd
July 2013 We're pleased to announce that Pearline Teo, SSB Fellow from 2012, has agreed to lead the curriculum work at the SSB center in Singapore. This will include the management of the Biodesign course that is offered at NUS, NTU and Duke NUS Medical schools.
June 2013 The SSB Special Lecture will feature distinguished guest speaker, Mr. William A. Hawkins, III. Mr William Hawkins is current CEO Immucor Inc. He served as Chairman and CEO of Medtronic (NYSE) from 2007 to 2011, one of the world’s largest and most innovative medical technology companies. And prior to that, he served as President and COO of Medtronic from 2004 to 2008.
May 2013 Our Singapore faculty and alumni fellows have created a device to preserve vascular access for hemodialysis. Two Singapore patents have been filed and Exploit Technologies Ltd is awarding SSB a S$1.5M grant to further the project.
June 2013 Faculty and fellows from the Singapore team are teaching an Innovation Workshop at National UKM in Malaysia
- Application for the 2014 Fellowship [application has closed]
About the Program
- Singapore-Stanford Biodesign (Singapore)
- Faculty & Staff
- Past News